![](https://cdn.sanity.io/images/0vv8moc6/onclive/b0f343dfb54f80e8e635a8f3583ced8b47a90b2d-200x200.webp?fit=crop&auto=format)
NICE Recommends Pembrolizumab Plus Chemo for Untreated HER2– Advanced Gastric/GEJ Adenocarcinoma
The National Institute for Health and Care Excellence has recommended the marketing authorization of pembrolizumab (Keytruda) paired with platinum- and fluoropyrimidine-based chemotherapy for the treatment of patients with untreated locally advanced …